SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences gets nod to form wholly owned subsidiary in US

11 Mar 2019 Evaluate

Suven Life Sciences has received approval to form Wholly Owned Subsidiary (WOS) Company -- Suven Pharma, Inc. a Delaware Company in US under CRAMS Division. The Board of Directors of the Company at its meeting held on March 09, 2019 has approved the same.

The board also approved investment of $75 million in the said WOS for new business opportunities and acquisitions etc.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

218.25 -5.90 (-2.63%)
11-May-2026 10:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.75
Dr. Reddys Lab 1284.60
Cipla 1334.95
Zydus Lifesciences 939.95
Lupin 2253.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×